Fundamental Analysis
52 / 100BRubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | -47.8% | +25.4% | 2 / 3 | +24.9% | -0.22 pp | -1.75 pp | +6.1% | 0.15 | 8.03 | 143 | +24,9% | 3,5 | −27,0% | 8.03 | 10.42 | −23,0% |
| Pts | 0 | 4 | 8 | 12 | 4 | 4 | 0 | 12 | 12 | |||||||
Valuation annotation:Price: 8.000 (close price on 2026-10-19)EPS (TTM): 996,6
Financial charts
1.Revenue & growth
VND bn143Q2/26
1.Revenue & growth
VND bn143Q2/26
2.Profit & growth
VND bn2,62Q2/26
3.Profit mix (Penman)
VND bn32,4Q2/26
4.Margins & cost structure
%17.5%Q2/26
5.Returns & cash cycle
% · days7.8%Q2/26
6.Earnings quality & cash
VND bn25,5Q2/26
7.Asset structure
VND bn558Q2/26
8.Funding & debt health
VND bn · times558Q2/26
9.Revenue backlog
VND bn15,7Q2/26
10.Valuation
times · %8,0×Q2/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %122Q2/26
Adjusted EPS growth, latest quarter
-47.8%
Average adjusted EPS growth, 3 quarters
-11.2%
averaged over 2 quarter(s)
Quarters at 25%+ growth
1/3
Share dilution rate, 1 year
0.0%
Source: vnstockData through Q2/26